4//SEC Filing
AMICUS THERAPEUTICS INC 4
Accession 0001209191-07-035695
$FOLDCIK 0001178879operating
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 8:17 PM ET
Size
40.8 KB
Accession
0001209191-07-035695
Insider Transaction Report
Form 4
PROSPECT VENTURE PARTNERS II LP
10% Owner
Transactions
- Conversion
Common Stock
2007-06-05+2,198,582→ 2,198,582 total(indirect: By Prospect Venture Partners II, L.P.) - Conversion
Series C Convertible Preferred Stock
2007-06-05−15,242(indirect: By Prospect Associates II, L.P.)→ Common Stock (15,242 underlying) - Exercise of In-Money
Common Stock
2007-06-05$6.38/sh+14,892$94,937→ 2,213,474 total(indirect: By Prospect Venture Partners II, L.P.) - Sale
Common Stock
2007-06-05$15.00/sh−97$1,455→ 33,608 total(indirect: By Prospect Associates II, L.P.) - Conversion
Series B Convertible Preferred Stock
2007-06-05−978,562(indirect: By Prospect Venture Partners II, L.P.)→ Common Stock (978,562 underlying) - Exercise of In-Money
Warrant to purchase Series B Preferred Stock
2007-06-05−227(indirect: By Prospect Associates II, L.P.)Exercise: $6.38→ Common Stock (227 underlying) - Exercise of In-Money
Warrant to purchase Series B Preferred Stock
2007-06-05−14,892(indirect: By Prospect Venture Partners II, L.P.)Exercise: $6.38→ Common Stock (14,892 underlying) - Conversion
Series C Convertible Preferred Stock
2007-06-05−1,000,978(indirect: By Prospect Venture Partners II, L.P.)→ Common Stock (1,000,978 underlying) - Conversion
Common Stock
2007-06-05+33,478→ 33,478 total(indirect: By Prospect Associates II, L.P.) - Sale
Common Stock
2007-06-05$15.00/sh−6,330$94,950→ 2,207,144 total(indirect: By Prospect Venture Partners II, L.P.) - Conversion
Series D Convertible Preferred Stock
2007-06-05−219,042(indirect: By Prospect Venture Partners II, L.P.)→ Common Stock (219,042 underlying) - Conversion
Series B Convertible Preferred Stock
2007-06-05−14,902(indirect: By Prospect Associates II, L.P.)→ Common Stock (14,902 underlying) - Conversion
Series D Convertible Preferred Stock
2007-06-05−3,334(indirect: By Prospect Associates II, L.P.)→ Common Stock (3,334 underlying) - Exercise of In-Money
Common Stock
2007-06-05$6.38/sh+227$1,447→ 33,705 total(indirect: By Prospect Associates II, L.P.)
PROSPECT MANAGEMENT CO II LLC
10% Owner
Transactions
- Conversion
Common Stock
2007-06-05+2,198,582→ 2,198,582 total(indirect: By Prospect Venture Partners II, L.P.) - Exercise of In-Money
Common Stock
2007-06-05$6.38/sh+227$1,447→ 33,705 total(indirect: By Prospect Associates II, L.P.) - Conversion
Series B Convertible Preferred Stock
2007-06-05−978,562(indirect: By Prospect Venture Partners II, L.P.)→ Common Stock (978,562 underlying) - Conversion
Series B Convertible Preferred Stock
2007-06-05−14,902(indirect: By Prospect Associates II, L.P.)→ Common Stock (14,902 underlying) - Conversion
Series C Convertible Preferred Stock
2007-06-05−1,000,978(indirect: By Prospect Venture Partners II, L.P.)→ Common Stock (1,000,978 underlying) - Sale
Common Stock
2007-06-05$15.00/sh−6,330$94,950→ 2,207,144 total(indirect: By Prospect Venture Partners II, L.P.) - Conversion
Series D Convertible Preferred Stock
2007-06-05−219,042(indirect: By Prospect Venture Partners II, L.P.)→ Common Stock (219,042 underlying) - Exercise of In-Money
Common Stock
2007-06-05$6.38/sh+14,892$94,937→ 2,213,474 total(indirect: By Prospect Venture Partners II, L.P.) - Conversion
Series D Convertible Preferred Stock
2007-06-05−3,334(indirect: By Prospect Associates II, L.P.)→ Common Stock (3,334 underlying) - Conversion
Common Stock
2007-06-05+33,478→ 33,478 total(indirect: By Prospect Associates II, L.P.) - Sale
Common Stock
2007-06-05$15.00/sh−97$1,455→ 33,608 total(indirect: By Prospect Associates II, L.P.) - Conversion
Series C Convertible Preferred Stock
2007-06-05−15,242(indirect: By Prospect Associates II, L.P.)→ Common Stock (15,242 underlying) - Exercise of In-Money
Warrant to purchase Series B Preferred Stock
2007-06-05−14,892(indirect: By Prospect Venture Partners II, L.P.)Exercise: $6.38→ Common Stock (14,892 underlying) - Exercise of In-Money
Warrant to purchase Series B Preferred Stock
2007-06-05−227(indirect: By Prospect Associates II, L.P.)Exercise: $6.38→ Common Stock (227 underlying)
PROSPECT ASSOCIATES II L P
10% Owner
Transactions
- Exercise of In-Money
Common Stock
2007-06-05$6.38/sh+227$1,447→ 33,705 total(indirect: By Prospect Associates II, L.P.) - Sale
Common Stock
2007-06-05$15.00/sh−97$1,455→ 33,608 total(indirect: By Prospect Associates II, L.P.) - Conversion
Series B Convertible Preferred Stock
2007-06-05−14,902(indirect: By Prospect Associates II, L.P.)→ Common Stock (14,902 underlying) - Sale
Common Stock
2007-06-05$15.00/sh−6,330$94,950→ 2,207,144 total(indirect: By Prospect Venture Partners II, L.P.) - Conversion
Common Stock
2007-06-05+33,478→ 33,478 total(indirect: By Prospect Associates II, L.P.) - Conversion
Series D Convertible Preferred Stock
2007-06-05−3,334(indirect: By Prospect Associates II, L.P.)→ Common Stock (3,334 underlying) - Conversion
Common Stock
2007-06-05+2,198,582→ 2,198,582 total(indirect: By Prospect Venture Partners II, L.P.) - Conversion
Series C Convertible Preferred Stock
2007-06-05−15,242(indirect: By Prospect Associates II, L.P.)→ Common Stock (15,242 underlying) - Conversion
Series B Convertible Preferred Stock
2007-06-05−978,562(indirect: By Prospect Venture Partners II, L.P.)→ Common Stock (978,562 underlying) - Conversion
Series C Convertible Preferred Stock
2007-06-05−1,000,978(indirect: By Prospect Venture Partners II, L.P.)→ Common Stock (1,000,978 underlying) - Conversion
Series D Convertible Preferred Stock
2007-06-05−219,042(indirect: By Prospect Venture Partners II, L.P.)→ Common Stock (219,042 underlying) - Exercise of In-Money
Warrant to purchase Series B Preferred Stock
2007-06-05−227(indirect: By Prospect Associates II, L.P.)Exercise: $6.38→ Common Stock (227 underlying) - Exercise of In-Money
Warrant to purchase Series B Preferred Stock
2007-06-05−14,892(indirect: By Prospect Venture Partners II, L.P.)Exercise: $6.38→ Common Stock (14,892 underlying) - Exercise of In-Money
Common Stock
2007-06-05$6.38/sh+14,892$94,937→ 2,213,474 total(indirect: By Prospect Venture Partners II, L.P.)
SCHNELL DAVID
10% Owner
Transactions
- Conversion
Common Stock
2007-06-05+33,478→ 33,478 total(indirect: By Prospect Associates II, L.P.) - Conversion
Series B Convertible Preferred Stock
2007-06-05−14,902(indirect: By Prospect Associates II, L.P.)→ Common Stock (14,902 underlying) - Conversion
Series C Convertible Preferred Stock
2007-06-05−15,242(indirect: By Prospect Associates II, L.P.)→ Common Stock (15,242 underlying) - Conversion
Series D Convertible Preferred Stock
2007-06-05−3,334(indirect: By Prospect Associates II, L.P.)→ Common Stock (3,334 underlying) - Sale
Common Stock
2007-06-05$15.00/sh−6,330$94,950→ 2,207,144 total(indirect: By Prospect Venture Partners II, L.P.) - Conversion
Series B Convertible Preferred Stock
2007-06-05−978,562(indirect: By Prospect Venture Partners II, L.P.)→ Common Stock (978,562 underlying) - Exercise of In-Money
Warrant to purchase Series B Preferred Stock
2007-06-05−14,892(indirect: By Prospect Venture Partners II, L.P.)Exercise: $6.38→ Common Stock (14,892 underlying) - Exercise of In-Money
Warrant to purchase Series B Preferred Stock
2007-06-05−227(indirect: By Prospect Associates II, L.P.)Exercise: $6.38→ Common Stock (227 underlying) - Exercise of In-Money
Common Stock
2007-06-05$6.38/sh+14,892$94,937→ 2,213,474 total(indirect: By Prospect Venture Partners II, L.P.) - Exercise of In-Money
Common Stock
2007-06-05$6.38/sh+227$1,447→ 33,705 total(indirect: By Prospect Associates II, L.P.) - Sale
Common Stock
2007-06-05$15.00/sh−97$1,455→ 33,608 total(indirect: By Prospect Associates II, L.P.) - Conversion
Common Stock
2007-06-05+2,198,582→ 2,198,582 total(indirect: By Prospect Venture Partners II, L.P.) - Conversion
Series C Convertible Preferred Stock
2007-06-05−1,000,978(indirect: By Prospect Venture Partners II, L.P.)→ Common Stock (1,000,978 underlying) - Conversion
Series D Convertible Preferred Stock
2007-06-05−219,042(indirect: By Prospect Venture Partners II, L.P.)→ Common Stock (219,042 underlying)
HIRSCH RUSSELL C
10% Owner
Transactions
- Exercise of In-Money
Common Stock
2007-06-05$6.38/sh+14,892$94,937→ 2,213,474 total(indirect: By Prospect Venture Partners II, L.P.) - Sale
Common Stock
2007-06-05$15.00/sh−97$1,455→ 33,608 total(indirect: By Prospect Associates II, L.P.) - Conversion
Common Stock
2007-06-05+2,198,582→ 2,198,582 total(indirect: By Prospect Venture Partners II, L.P.) - Exercise of In-Money
Warrant to purchase Series B Preferred Stock
2007-06-05−227(indirect: By Prospect Associates II, L.P.)Exercise: $6.38→ Common Stock (227 underlying) - Conversion
Common Stock
2007-06-05+33,478→ 33,478 total(indirect: By Prospect Associates II, L.P.) - Sale
Common Stock
2007-06-05$15.00/sh−6,330$94,950→ 2,207,144 total(indirect: By Prospect Venture Partners II, L.P.) - Conversion
Series C Convertible Preferred Stock
2007-06-05−15,242(indirect: By Prospect Associates II, L.P.)→ Common Stock (15,242 underlying) - Exercise of In-Money
Common Stock
2007-06-05$6.38/sh+227$1,447→ 33,705 total(indirect: By Prospect Associates II, L.P.) - Conversion
Series B Convertible Preferred Stock
2007-06-05−14,902(indirect: By Prospect Associates II, L.P.)→ Common Stock (14,902 underlying) - Conversion
Series B Convertible Preferred Stock
2007-06-05−978,562(indirect: By Prospect Venture Partners II, L.P.)→ Common Stock (978,562 underlying) - Exercise of In-Money
Warrant to purchase Series B Preferred Stock
2007-06-05−14,892(indirect: By Prospect Venture Partners II, L.P.)Exercise: $6.38→ Common Stock (14,892 underlying) - Conversion
Series C Convertible Preferred Stock
2007-06-05−1,000,978(indirect: By Prospect Venture Partners II, L.P.)→ Common Stock (1,000,978 underlying) - Conversion
Series D Convertible Preferred Stock
2007-06-05−219,042(indirect: By Prospect Venture Partners II, L.P.)→ Common Stock (219,042 underlying) - Conversion
Series D Convertible Preferred Stock
2007-06-05−3,334(indirect: By Prospect Associates II, L.P.)→ Common Stock (3,334 underlying)
TANANBAUM JAMES B
10% Owner
Transactions
- Exercise of In-Money
Common Stock
2007-06-05$6.38/sh+227$1,447→ 33,705 total(indirect: By Prospect Associates II, L.P.) - Conversion
Series C Convertible Preferred Stock
2007-06-05−1,000,978(indirect: By Prospect Venture Partners II, L.P.)→ Common Stock (1,000,978 underlying) - Exercise of In-Money
Warrant to purchase Series B Preferred Stock
2007-06-05−14,892(indirect: By Prospect Venture Partners II, L.P.)Exercise: $6.38→ Common Stock (14,892 underlying) - Conversion
Series C Convertible Preferred Stock
2007-06-05−15,242(indirect: By Prospect Associates II, L.P.)→ Common Stock (15,242 underlying) - Conversion
Series D Convertible Preferred Stock
2007-06-05−219,042(indirect: By Prospect Venture Partners II, L.P.)→ Common Stock (219,042 underlying) - Exercise of In-Money
Common Stock
2007-06-05$6.38/sh+14,892$94,937→ 2,213,474 total(indirect: By Prospect Venture Partners II, L.P.) - Conversion
Series D Convertible Preferred Stock
2007-06-05−3,334(indirect: By Prospect Associates II, L.P.)→ Common Stock (3,334 underlying) - Conversion
Common Stock
2007-06-05+2,198,582→ 2,198,582 total(indirect: By Prospect Venture Partners II, L.P.) - Conversion
Common Stock
2007-06-05+33,478→ 33,478 total(indirect: By Prospect Associates II, L.P.) - Conversion
Series B Convertible Preferred Stock
2007-06-05−978,562(indirect: By Prospect Venture Partners II, L.P.)→ Common Stock (978,562 underlying) - Conversion
Series B Convertible Preferred Stock
2007-06-05−14,902(indirect: By Prospect Associates II, L.P.)→ Common Stock (14,902 underlying) - Exercise of In-Money
Warrant to purchase Series B Preferred Stock
2007-06-05−227(indirect: By Prospect Associates II, L.P.)Exercise: $6.38→ Common Stock (227 underlying) - Sale
Common Stock
2007-06-05$15.00/sh−6,330$94,950→ 2,207,144 total(indirect: By Prospect Venture Partners II, L.P.) - Sale
Common Stock
2007-06-05$15.00/sh−97$1,455→ 33,608 total(indirect: By Prospect Associates II, L.P.)
Footnotes (7)
- [F1]Each share of the Issuer's Preferred Stock converted automatically into shares of the Issuer's Common Stock on a 1-for-1 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.
- [F2]The shares are owned by Prospect Venture Partners II, L.P. ("PVP II"), which is under common control with Prospect Associates II, L.P. ("PA II"). Prospect Management Co. II, L.L.C. ("PMC II") serves as the sole general partner of PVP II. James B. Tananbaum, M.D., Alexander E. Barkas, Ph.D., David Schnell, M.D., and Russell C. Hirsch, M.D., Ph.D. are the Managing Directors of PMC II and shares voting and investment power over the shares held by PVP II. Each reporting person disclaims beneficial ownership of the shares reported herein, except to the extent of his proportionate pecuniary interest therein. Dr. Barkas is a director of the Issuer and, accordingly, files separate Section 16 reports.
- [F3]The shares are owned by PA II. PMC II serves as the sole general partner of PA II. James B. Tananbaum, M.D., Alexander E. Barkas, Ph.D., David Schnell, M.D., and Russell C. Hirsch, M.D., Ph.D. are the Managing Directors of PMC II and shares voting and investment power over the shares held by PA II. Each reporting person disclaims beneficial ownership of the shares reported herein, except to the extent of his proportionate pecuniary interest therein. Dr. Barkas is a director of the Issuer and, accordingly, files separate Section 16 reports.
- [F4]Net exercise of warrant held by PVP II for an aggregate acquisition of 8,562 shares of Common Stock.
- [F5]Net exercise of warrant held by PA II for an aggregate acquisition of 130 shares of Common Stock.
- [F6]The warrant is owned by PVP II and is immediately exercisable. The warrant was net exercised upon the closing of the Issuer's initial public offering.
- [F7]The warrant is owned by PA II and is immediately exercisable. The warrant was net exercised upon the closing of the Issuer's initial public offering.
Documents
Issuer
AMICUS THERAPEUTICS INC
CIK 0001178879
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001178879
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 8:17 PM ET
- Size
- 40.8 KB